Market Leadership MVE Biological Solutions is the global leader in cryogenic storage and shipping devices, serving diverse sectors such as biopharma, cell and gene therapies, and medical research, making it a prime target for businesses seeking reliable low-temperature biological material solutions.

Recent Acquisition Since Cryoport's acquisition of MVE in 2020, the company benefits from enhanced distribution channels and integrated supply chain solutions, presenting opportunities to cross-sell complementary logistics and storage services to existing clients.

Innovative Recognition Winning the ISBER Outstanding New Product Award for MVE Fusion highlights the company's focus on innovation and quality, making it an attractive partner for entities seeking cutting-edge cryogenic technology and high standard solutions.

Growth Potential With an annual revenue estimated between $10 million to $25 million and a dedicated team of up to 200 employees, MVE is positioned for growth within the specialized biological storage market, offering scalability opportunities for strategic partners.

Industry Trends The company's focus on cryogenic storage aligns with the increasing global demand for reliable biological material preservation, especially in emerging biotechnologies and regenerative medicine, opening avenues for innovative product and service collaborations.